Table 4.
Positive rate and timing of anti-Eno and anti-Fba1 antibodies in non-neutropenic and neutropenic patients with candidemia [n (%)]
| Population (No. of subjects) |
Anti-Eno |
Anti-Fba1 |
||||
|---|---|---|---|---|---|---|
| Ab* (+) prior to BC(+) | BC**(+) prior to Ab(+) | Total | Ab(+) prior to BC(+) | BC(+) prior to Ab(+) | Total | |
| Non-neutropenia (90) |
38 (42.2) |
31 (34.4) |
69 (76.7) |
46 (51.1) |
37 (41.1) |
83 (92.2) |
| Neutropenia# (11) |
3 (27.3) |
1 (9.1) |
4 (36.4)a |
4 (36.4) |
1 (9.1) |
5 (45.5)b |
| Total (101) | 41 (40.6) | 32 (31.7) | 73 (72.3) | 50 (49.5) | 38 (37.6) | 88 (87.1) |
*Ab: antibody, ** BC: blood culture.
#Neutropenia was defined as an absolute neutrophil count below 500 cells/mm3.
aP = 0.005, for the comparison with the Non-neutropenia group.
bP < 0.001, for the comparison with the Non-neutropenia group.